Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
163%
upside
9 price targets
|
0
%
|
|
|
|
156%
upside
3 price targets
|
0
%
|
|
|
|
135%
upside
6 price targets
|
0
%
|
|
|
4
Ocular Therapeutix
OCUL
$2.11B
|
131%
upside
3 price targets
|
0
%
|
|
|
126%
upside
4 price targets
|
0
%
|
|
|
|
113%
upside
14 price targets
|
0
%
|
|
|
|
104%
upside
6 price targets
|
0
%
|
|
|
|
101%
upside
5 price targets
|
0
%
|
|
|
|
98%
upside
8 price targets
|
0
%
|
|
|
|
97%
upside
4 price targets
|
0
%
|
|
|
11
Erasca
ERAS
$3.15B
|
92%
upside
5 price targets
|
0
%
|
|
|
91%
upside
4 price targets
|
0
%
|
|
|
|
89%
upside
4 price targets
|
0
%
|
|
|
|
86%
upside
3 price targets
|
0
%
|
|
|
|
86%
upside
7 price targets
|
0
%
|
|
|
|
85%
upside
4 price targets
|
0
%
|
|
|
|
84%
upside
3 price targets
|
0
%
|
|
|
|
82%
upside
3 price targets
|
0
%
|
|
|
|
82%
upside
4 price targets
|
0
%
|
|
|
|
80%
upside
4 price targets
|
0
%
|
|
|
|
80%
upside
4 price targets
|
0
%
|
|
|
|
80%
upside
12 price targets
|
0
%
|
|
|
|
75%
upside
12 price targets
|
0
%
|
|
|
|
73%
upside
4 price targets
|
0
%
|
|
|
|
73%
upside
6 price targets
|
0
%
|
|